[HTML][HTML] Distinct landscape and clinical implications of therapy-related clonal hematopoiesis

K Takahashi, D Nakada, M Goodell - The Journal of Clinical Investigation, 2024 - jci.org
Therapy-related clonal hematopoiesis (t-CH) is defined as clonal hematopoiesis detected in
individuals previously treated with chemotherapy and/or radiation therapy. With the …

[HTML][HTML] CHIP: a clonal odyssey of the bone marrow niche

WE Schleicher, B Hoag, M De Dominici… - The Journal of Clinical …, 2024 - jci.org
Clonal hematopoiesis of indeterminate potential (CHIP) is characterized by the selective
expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations …

Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations

F Gutierrez-Rodrigues, EM Groarke, N Thongon… - Blood …, 2024 - ashpublications.org
Telomere biology disorders (TBD), caused by pathogenic germline variants in telomere-
related genes, present with multi-organ disease and a predisposition to cancer. Clonal …

PPM1G promotes autophagy and progression of pancreatic cancer via upregulating HMGB1

M Song, M Xu, Q Zhang, T Fan, J Xu, C Hang… - Cellular …, 2024 - Elsevier
Pancreatic cancer remains one of the most aggressive and lethal malignancies worldwide,
with a dismal 5-year relative survival rates of only 12%. Therefore, it is urgent to discover the …

[HTML][HTML] PPM1D activity promotes cellular transformation by preventing senescence and cell death

M Stoyanov, AS Martinikova, K Matejkova… - Oncogene, 2024 - nature.com
Cell cycle checkpoints, oncogene-induced senescence and programmed cell death
represent intrinsic barriers to tumorigenesis. Protein phosphatase magnesium-dependent 1 …

[HTML][HTML] Clonal hematopoiesis in children with predisposing conditions

E Attardi, SJ Corey, MW Wlodarski - Seminars in Hematology, 2024 - Elsevier
Clonal hematopoiesis in children and young adults differs from that occuring in the older
adult population. A variety of stressors drive this phenomenon, sometimes independent of …

[HTML][HTML] The role of clonal progression leading to the development of therapy-related myeloid neoplasms

L Guarnera, MR Pascale, H Hajrullaj, A Cristiano… - Annals of …, 2024 - Springer
Therapy-related myeloid neoplasms (t-MN) are characterized by aggressive features and a
dismal prognosis. Recent evidence suggests a higher incidence of t-MN in individuals …

[HTML][HTML] Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment

D Singhal, MM Kutyna, CN Hahn, MV Shah… - Blood Cancer …, 2024 - aacrjournals.org
Therapy-related myeloid neoplasm (t-MN), characterized by its association with prior
exposure to cytotoxic therapy, remains poorly understood and is a major impediment to long …

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

CH Marshall, LP Gondek, V Daniels, C Lu… - The …, 2024 - Wiley Online Library
Background Poly ADP‐ribose polymerase (PARP) inhibitors are approved for the treatment
of some men with advanced prostate cancer. Rare but serious side effects include …

[HTML][HTML] Hematopoietic stem cell fate under the influence of Ser/Thr protein phosphatases

M Alberich-Jorda, L Macurek - Haematologica, 2024 - pmc.ncbi.nlm.nih.gov
Hematopoietic stem cells (HSC) are multipotent cells capable of unlimited self-renewal and
are essential for production of blood and immune cells throughout life. HSC reside in a …